NCT04081844

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

An Open-label, Multiple Dose, Fixed-sequence, 3-period Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608 and HCP1306 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

An Open-label, Multiple-dose, Fixed-sequence, 3-Period Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions between HGP0904, HGP0608 and HCP1306 in Healthy Male Subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HCP1306	Ezetimibe 10mg / Rosuvastatin 20mg (Rosuzet)
DRUG	HGP0904	Amlodipine 5mg(Norvasc)
DRUG	HGP0608	Losartan 100mg(Cozaar)

Timeline

• Start date: 2018-05-03
• Primary completion: 2018-06-28
• Completion: 2018-06-28
• First posted: 2019-09-09
• Last updated: 2019-09-09

Locations

1 site across 1 country: South Korea